These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. 8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis. Malli F; Bardaka F; Tsilioni I; Karetsi E; Gourgoulianis KI; Daniil Z Food Chem Toxicol; 2013 Nov; 61():160-3. PubMed ID: 23702326 [TBL] [Abstract][Full Text] [Related]
6. Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular-weight antioxidants in patients with different forms of chronic fibrosing interstitial lung diseases. Markart P; Luboeinski T; Korfei M; Schmidt R; Wygrecka M; Mahavadi P; Mayer K; Wilhelm J; Seeger W; Guenther A; Ruppert C Antioxid Redox Signal; 2009 Feb; 11(2):227-40. PubMed ID: 18783310 [TBL] [Abstract][Full Text] [Related]
13. The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin. Veith C; Drent M; Bast A; van Schooten FJ; Boots AW Toxicol Appl Pharmacol; 2017 Dec; 336():40-48. PubMed ID: 28987380 [TBL] [Abstract][Full Text] [Related]
14. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis. Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187 [TBL] [Abstract][Full Text] [Related]
15. Increased Expression of CC16 in Patients with Idiopathic Pulmonary Fibrosis. Buendía-Roldán I; Ruiz V; Sierra P; Montes E; Ramírez R; Vega A; Salgado A; Vargas MH; Mejía M; Pardo A; Selman M PLoS One; 2016; 11(12):e0168552. PubMed ID: 27977812 [TBL] [Abstract][Full Text] [Related]
17. A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls. Landi C; Bargagli E; Carleo A; Bianchi L; Gagliardi A; Prasse A; Perari MG; Refini RM; Bini L; Rottoli P Proteomics Clin Appl; 2014 Dec; 8(11-12):932-50. PubMed ID: 25169739 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: protocol for a systematic review. Kamiya H; Panlaqui OM BMJ Open; 2018 Mar; 8(3):e020862. PubMed ID: 29523572 [TBL] [Abstract][Full Text] [Related]
19. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis. Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180 [TBL] [Abstract][Full Text] [Related]
20. Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD. Ishikawa N; Ohlmeier S; Salmenkivi K; Myllärniemi M; Rahman I; Mazur W; Kinnula VL Respir Res; 2010 Sep; 11(1):123. PubMed ID: 20836851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]